April 20, 2018 / 2:13 PM / 6 months ago

BRIEF-FDA Takes Steps To Advance Development Of Opioid Use Disorder Treatment

April 20 (Reuters) - U.S. FDA:

* U.S. FDA TAKES NEW STEPS TO ADVANCE THE DEVELOPMENT OF INNOVATIVE PRODUCTS FOR TREATING OPIOID USE DISORDER

* U.S. FDA - FIRST GUIDANCE EXPLAINS FDA’S THINKING ON ISSUES RELEVANT TO SUSTAINED-RELEASE “DEPOT” BUPRENORPHINE PRODUCTS STUDY

* FDA - WILL ISSUE ADDITIONAL GUIDANCE ON DEVELOPING NOVEL CLINICAL ENDPOINTS WHICH FORM BASIS OF MEDICATION-ASSISTED TREATMENT PRODUCT APPROVALS Source text : (bit.ly/2HgARje)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below